PTHrP can serve as a biomarker for hypercalcemia of malignancy and may provide diagnostic and prognostic information. Elevated PTHrP levels in patients with known malignancies can help differentiate hypercalcemia of malignancy from other causes of elevated calcium, such as primary hyperparathyroidism.
